US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 12.120
  • +0.650+5.67%
Close Nov 25 16:00 ET
  • 12.120
  • 0.0000.00%
Post 20:01 ET
69.81MMarket Cap-478P/E (TTM)

Atara Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
92.23%-3.99M
79.84%-10.65M
22.94%-29.61M
28.64%-192.98M
11.38%-50.41M
21.08%-51.35M
17.46%-52.8M
54.54%-38.43M
-22.63%-270.43M
-65.98%-56.88M
Net income from continuing operations
68.61%-21.91M
73.21%-19.05M
57.53%-31.75M
-20.95%-276.13M
18.94%-60.45M
17.00%-69.8M
-485.08%-71.11M
15.13%-74.77M
32.88%-228.3M
20.11%-74.57M
Operating gains losses
----
----
----
----
----
----
----
----
---50.24M
--0
Depreciation and amortization
1.74%1.23M
10.74%1.33M
14.58%1.39M
-14.58%4.83M
-3.98%1.21M
-11.69%1.21M
-16.48%1.2M
-23.70%1.21M
-39.51%5.65M
-49.56%1.26M
Other non cash items
-13.31%3.76M
-2.11%4.13M
-2.76%4.05M
85.40%16.8M
41.12%4.08M
56.60%4.34M
52.51%4.22M
556.62%4.16M
340.76%9.06M
302.93%2.89M
Change In working capital
232.76%6.56M
-409.23%-3.38M
-160.01%-11.73M
124.96%15.34M
-440.84%-7.28M
178.93%1.97M
102.15%1.09M
245.02%19.55M
-216.89%-61.47M
-94.83%2.14M
-Change in receivables
215.99%1.09M
30,474.55%33.41M
-104.33%-1.73M
115.58%6.11M
15.08%-33.95M
-11.34%344K
-454.84%-110K
12,423.27%39.82M
-14,961.74%-39.24M
-3,953.96%-39.97M
-Change in inventory
275.51%4.77M
-5.71%-2.67M
-69.90%-6.38M
-411.98%-8.12M
-96.41%-3.12M
--1.27M
---2.52M
---3.75M
---1.59M
---1.59M
-Change in payables and accrued expense
-213.60%-2.8M
-193.53%-11.52M
27.31%-2.26M
-391.55%-6.79M
-183.09%-2.22M
-75.85%2.46M
39.59%-3.92M
23.14%-3.11M
-65.25%2.33M
-30.28%2.67M
-Change in other current assets
-602.16%-3.73M
-30.15%1.96M
40.95%-1.62M
-16.18%1.32M
-90.82%515K
118.02%742K
11,096.00%2.8M
-5,472.55%-2.74M
-75.68%1.57M
-12.69%5.61M
-Change in other current liabilities
4.87%-5.69M
-728.12%-10.41M
50.56%-2.42M
74.41%-1.43M
267.33%7.77M
-2,632.20%-5.98M
2,816.39%1.66M
-337.33%-4.89M
-645.07%-5.59M
-206.46%-4.65M
-Change in other working capital
312.75%12.92M
-543.67%-14.16M
146.12%2.67M
227.93%24.26M
-40.79%23.72M
141.47%3.13M
107.57%3.19M
37.80%-5.78M
-147.50%-18.96M
-9.81%40.05M
Cash from discontinued investing activities
Operating cash flow
92.23%-3.99M
79.84%-10.65M
22.94%-29.61M
28.64%-192.98M
11.38%-50.41M
21.08%-51.35M
17.46%-52.8M
54.54%-38.43M
-22.63%-270.43M
-65.98%-56.88M
Investing cash flow
Cash flow from continuing investing activities
-123.66%-16.67M
-85.46%7.2M
345.00%14.72M
-38.97%123.87M
-80.58%9.94M
18.01%70.45M
55.48%49.48M
-109.98%-6.01M
811.83%202.96M
310.57%51.22M
Net PPE purchase and sale
--0
94.19%-29K
68.17%-127K
-101.32%-1.2M
-18.92%-44K
-93.94%-256K
-100.53%-499K
84.68%-399K
956.07%90.57M
98.50%-37K
Net investment purchase and sale
-123.57%-16.67M
-85.54%7.23M
364.69%14.84M
11.28%125.06M
-80.51%9.99M
18.18%70.7M
181.24%49.98M
-108.93%-5.61M
242.24%112.38M
334.49%51.26M
Cash from discontinued investing activities
Investing cash flow
-123.66%-16.67M
-85.46%7.2M
345.00%14.72M
-38.97%123.87M
-80.58%9.94M
18.01%70.45M
55.48%49.48M
-109.98%-6.01M
811.83%202.96M
310.57%51.22M
Financing cash flow
Cash flow from continuing financing activities
17,308.17%35.79M
-168.79%-324K
10,172.77%24.14M
-96.21%2.01M
-95.32%1.51M
2.80%-208K
-59.29%471K
-98.82%235K
-48.93%53.08M
-37.26%32.29M
Net issuance payments of debt
5.29%-197K
-9.91%-233K
27.24%-227K
-82.82%-947K
-76.23%-215K
-0.97%-208K
-68.25%-212K
-387.50%-312K
-103.94%-518K
-96.77%-122K
Net common stock issuance
--50.81M
-29,952.00%-15.03M
3,708.44%24.37M
-90.24%2.14M
12.44%1.55M
--0
-117.39%-50K
-96.88%640K
-77.82%21.89M
-97.25%1.38M
Proceeds from stock option exercised by employees
--0
-84.87%113K
--0
-51.69%928K
-61.41%181K
--0
-42.93%747K
--0
-71.59%1.92M
-70.17%469K
Net other financing activities
--0
92.86%-1K
93.55%-6K
-100.36%-107K
--0
--0
-366.67%-14K
87.08%-93K
2,462.41%29.79M
--30.57M
Cash from discontinued financing activities
Financing cash flow
17,308.17%35.79M
-168.79%-324K
10,172.77%24.14M
-96.21%2.01M
-95.32%1.51M
2.80%-208K
-59.29%471K
-98.82%235K
-48.93%53.08M
-37.26%32.29M
Net cash flow
Beginning cash position
-31.67%31.46M
-27.93%35.23M
-72.08%25.99M
-13.39%93.09M
-2.29%64.94M
-36.08%46.04M
-52.54%48.89M
-13.39%93.09M
-46.74%107.48M
-42.01%66.46M
Current changes in cash
-19.87%15.14M
-32.71%-3.77M
120.92%9.25M
-366.30%-67.1M
-246.27%-38.95M
438.95%18.89M
90.82%-2.84M
-890.39%-44.2M
84.74%-14.39M
473.73%26.63M
End cash Position
-28.24%46.6M
-31.67%31.46M
-27.93%35.23M
-72.08%25.99M
-72.08%25.99M
-2.29%64.94M
-36.08%46.04M
-52.54%48.89M
-13.39%93.09M
-13.39%93.09M
Free cash flow
92.27%-3.99M
79.97%-10.67M
23.41%-29.74M
29.28%-194.2M
11.36%-50.45M
20.80%-51.63M
18.49%-53.3M
55.44%-38.83M
-18.83%-274.62M
-54.94%-56.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 92.23%-3.99M79.84%-10.65M22.94%-29.61M28.64%-192.98M11.38%-50.41M21.08%-51.35M17.46%-52.8M54.54%-38.43M-22.63%-270.43M-65.98%-56.88M
Net income from continuing operations 68.61%-21.91M73.21%-19.05M57.53%-31.75M-20.95%-276.13M18.94%-60.45M17.00%-69.8M-485.08%-71.11M15.13%-74.77M32.88%-228.3M20.11%-74.57M
Operating gains losses -----------------------------------50.24M--0
Depreciation and amortization 1.74%1.23M10.74%1.33M14.58%1.39M-14.58%4.83M-3.98%1.21M-11.69%1.21M-16.48%1.2M-23.70%1.21M-39.51%5.65M-49.56%1.26M
Other non cash items -13.31%3.76M-2.11%4.13M-2.76%4.05M85.40%16.8M41.12%4.08M56.60%4.34M52.51%4.22M556.62%4.16M340.76%9.06M302.93%2.89M
Change In working capital 232.76%6.56M-409.23%-3.38M-160.01%-11.73M124.96%15.34M-440.84%-7.28M178.93%1.97M102.15%1.09M245.02%19.55M-216.89%-61.47M-94.83%2.14M
-Change in receivables 215.99%1.09M30,474.55%33.41M-104.33%-1.73M115.58%6.11M15.08%-33.95M-11.34%344K-454.84%-110K12,423.27%39.82M-14,961.74%-39.24M-3,953.96%-39.97M
-Change in inventory 275.51%4.77M-5.71%-2.67M-69.90%-6.38M-411.98%-8.12M-96.41%-3.12M--1.27M---2.52M---3.75M---1.59M---1.59M
-Change in payables and accrued expense -213.60%-2.8M-193.53%-11.52M27.31%-2.26M-391.55%-6.79M-183.09%-2.22M-75.85%2.46M39.59%-3.92M23.14%-3.11M-65.25%2.33M-30.28%2.67M
-Change in other current assets -602.16%-3.73M-30.15%1.96M40.95%-1.62M-16.18%1.32M-90.82%515K118.02%742K11,096.00%2.8M-5,472.55%-2.74M-75.68%1.57M-12.69%5.61M
-Change in other current liabilities 4.87%-5.69M-728.12%-10.41M50.56%-2.42M74.41%-1.43M267.33%7.77M-2,632.20%-5.98M2,816.39%1.66M-337.33%-4.89M-645.07%-5.59M-206.46%-4.65M
-Change in other working capital 312.75%12.92M-543.67%-14.16M146.12%2.67M227.93%24.26M-40.79%23.72M141.47%3.13M107.57%3.19M37.80%-5.78M-147.50%-18.96M-9.81%40.05M
Cash from discontinued investing activities
Operating cash flow 92.23%-3.99M79.84%-10.65M22.94%-29.61M28.64%-192.98M11.38%-50.41M21.08%-51.35M17.46%-52.8M54.54%-38.43M-22.63%-270.43M-65.98%-56.88M
Investing cash flow
Cash flow from continuing investing activities -123.66%-16.67M-85.46%7.2M345.00%14.72M-38.97%123.87M-80.58%9.94M18.01%70.45M55.48%49.48M-109.98%-6.01M811.83%202.96M310.57%51.22M
Net PPE purchase and sale --094.19%-29K68.17%-127K-101.32%-1.2M-18.92%-44K-93.94%-256K-100.53%-499K84.68%-399K956.07%90.57M98.50%-37K
Net investment purchase and sale -123.57%-16.67M-85.54%7.23M364.69%14.84M11.28%125.06M-80.51%9.99M18.18%70.7M181.24%49.98M-108.93%-5.61M242.24%112.38M334.49%51.26M
Cash from discontinued investing activities
Investing cash flow -123.66%-16.67M-85.46%7.2M345.00%14.72M-38.97%123.87M-80.58%9.94M18.01%70.45M55.48%49.48M-109.98%-6.01M811.83%202.96M310.57%51.22M
Financing cash flow
Cash flow from continuing financing activities 17,308.17%35.79M-168.79%-324K10,172.77%24.14M-96.21%2.01M-95.32%1.51M2.80%-208K-59.29%471K-98.82%235K-48.93%53.08M-37.26%32.29M
Net issuance payments of debt 5.29%-197K-9.91%-233K27.24%-227K-82.82%-947K-76.23%-215K-0.97%-208K-68.25%-212K-387.50%-312K-103.94%-518K-96.77%-122K
Net common stock issuance --50.81M-29,952.00%-15.03M3,708.44%24.37M-90.24%2.14M12.44%1.55M--0-117.39%-50K-96.88%640K-77.82%21.89M-97.25%1.38M
Proceeds from stock option exercised by employees --0-84.87%113K--0-51.69%928K-61.41%181K--0-42.93%747K--0-71.59%1.92M-70.17%469K
Net other financing activities --092.86%-1K93.55%-6K-100.36%-107K--0--0-366.67%-14K87.08%-93K2,462.41%29.79M--30.57M
Cash from discontinued financing activities
Financing cash flow 17,308.17%35.79M-168.79%-324K10,172.77%24.14M-96.21%2.01M-95.32%1.51M2.80%-208K-59.29%471K-98.82%235K-48.93%53.08M-37.26%32.29M
Net cash flow
Beginning cash position -31.67%31.46M-27.93%35.23M-72.08%25.99M-13.39%93.09M-2.29%64.94M-36.08%46.04M-52.54%48.89M-13.39%93.09M-46.74%107.48M-42.01%66.46M
Current changes in cash -19.87%15.14M-32.71%-3.77M120.92%9.25M-366.30%-67.1M-246.27%-38.95M438.95%18.89M90.82%-2.84M-890.39%-44.2M84.74%-14.39M473.73%26.63M
End cash Position -28.24%46.6M-31.67%31.46M-27.93%35.23M-72.08%25.99M-72.08%25.99M-2.29%64.94M-36.08%46.04M-52.54%48.89M-13.39%93.09M-13.39%93.09M
Free cash flow 92.27%-3.99M79.97%-10.67M23.41%-29.74M29.28%-194.2M11.36%-50.45M20.80%-51.63M18.49%-53.3M55.44%-38.83M-18.83%-274.62M-54.94%-56.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data